Sort by
Refine Your Search
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. POSITION SUMMARY The Cell Culture Technologies Team (CCTT) in
-
utilize cutting-edge chemical and biological tools to support our pre-clinical drug discovery programs. We are seeking an experienced cell and molecular biologist to contribute to the success
-
, and perform flow cytometry and immunoassay-based assays to support preclinical and clinical studies. Conduct cell-based immunoassays on preclinical and clinical samples in accordance with Good Clinical
-
researcher with strong cell and chemical biology laboratory experience. As a Scientist in Chemoproteomics, your research will drive a deeper understanding of tumor biology by assessing target engagement, off
-
, and perform flow cytometry-based and other biomarker assays to support preclinical and clinical studies. Conduct cell-based immunoassays on preclinical and clinical samples in accordance with Good
-
As a member of a team of scientists in our In Vivo Pharmacology Cancer Cell Biology Group, you will play a lead role in using models of cancer to evaluate new drug candidates, mechanisms, and
-
ligand binding and cell-based assays suitable for biotherapeutics quantification and immunogenicity assessment in various biological matrices using a range of potential platforms and assay techniques. You
-
a highly motivated Cell and Molecular Biologist to join Biotherapeutics Expression and Purification group (BEP) located in Pfizer Worldwide Biotherapeutics Research campus of Cambridge MA . Qualified
-
Unit, which is focused on anti-tumor immunity and immune cell biology to support the execution and diversification of the Oncology Research pipeline. The incumbent will be an established scientific
-
& Discovery and supporting partner lines. Participate in collaborations on novel T cell/DC targets with internal and external collaborators. Assist Lead Biomarker Scientist to develop, optimize, validate, and